… We conducted this systematic review and metaanalysis to synthesize the existing evidence
… While a number of systematic reviews and metaanalyses have examined the performance of …

… An increasing trend of incidence in hepatocellular carcinoma (HCC) has been recorded in
most developed countries. HCC ranks among the ten most common cancers worldwide. The …

… There are several limitations in this meta-analysis. Because … meta-analysis. It is not
ideal to combine randomized controlled trials, case–control and cohort studies in one meta-analysis …

The aim of the study was to assess whether coinfection by hepatitisB virus (HBV) and
hepatitisC virus (HCV) is associated with a higher risk of developing hepatocellular carcinoma (…

Background & Aims Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for
hepatocellular carcinoma (HCC), but the extent of this association still needs to be addressed. …

… contrast for detection of patients with hepatocellular carcinoma in surveillance settings. …
contrast for detection of patients with hepatocellular carcinoma in nonsurveillance settings. …

… However, the single large placebo-controlled trial,44 still unpublished as a full paper,
reported 1-year and 2-year survival rates similar to that given in this metaanalysis. …

Background & Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer-related
mortality, with a rapidly changing landscape of treatments. In the past 20 years, numerous …

… Studies of diabetes and hepatocellular carcinoma (HCC) yielded inconsistent findings. This
meta-analysis was conducted to examine the association between diabetes and risk of HCC. …

Background Intrahepatic recurrence of hepatocellular carcinoma (HCC) following resection
is common. However, no current consensus guidelines exist to inform management …